Stockscreener 앱 받기
0.418
5.62%
-0.0249
시간 외 거래:
.42
0.002
+0.48%
Jaguar Health Inc 주식(JAGX)의 최신 뉴스
Jaguar Health (JAGX) Advances Pediatric Crofelemer Study - GuruFocus
FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Yahoo Finance
Published on: 2026-03-19 06:11:46 - baoquankhu1.vn
Earnings Recap: Is Jaguar Health Inc stock a top performer YTDDay Trade & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Seacoastonline.com
Jaguar Health unit begins coca extract study for weight management By Investing.com - Investing.com South Africa
Jaguar Health (JAGX) Launches Preclinical Study on Coca Leaf Ext - GuruFocus
Jaguar Health unit begins coca extract study for weight management - Investing.com
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - ACCESS Newswire
Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - FinanzNachrichten.de
Performance Recap: Will Jaguar Health Inc benefit from AI trends2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Jaguar Health (NASDAQ: JAGX) asks shareholders to OK reverse splits, large potential dilution - Stock Titan
JAGX Stock Price, Quote & Chart | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health at Life Sciences Forum: Strategic Shift to Rare Diseases - Investing.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Sheboygan Press
Director John Micek granted stock options and RSUs at Jaguar Health (JAGX) - Stock Titan
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts - Bradenton Herald
User - The Chronicle-Journal
Published on: 2026-03-11 18:03:23 - baoquankhu1.vn
Jaguar Health CEO to outline 'near-term catalysts' at virtual investor forum - Stock Titan
Jaguar Health (JAGX) Restructures Debt and Reduces Royalties - GuruFocus
Jaguar Health, Inc. Enters Global Amendment Agreements and Security Agreement – March 2026 8-K Filing Details - Minichart
According to the latest SEC filing, Jaguar Health Inc (NASDAQ: JAGX) has completed the amendment to the Uptown 2020 royalty interest agreement. - Bitget
Jaguar Animal Health Restructures Debt and Royalty Agreements - TipRanks
Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants - ACCESS Newswire
Jaguar Health Extends Debt, Defers Royalty Payments; Terminates 48,211-Share Warrants - TradingView
Debt extensions and warrant termination reshape Jaguar Health (NASDAQ: JAGX) - Stock Titan
Jaguar Health trims $3M in debt and royalties, extends loans to July 2026 - Stock Titan
Jaguar Health executes strategic stock exchange agreements - MSN
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1 - ACCESS Newswire
JAGXJaguar Health Announces a Special One-time Stock Dividend - mx.advfn.com
Jaguar Health receives Nasdaq delisting notice after share price falls below $1 - Investing.com
Revenue Check: Is Jaguar Health Inc gaining market shareJuly 2025 Weekly Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Jaguar Health Faces Nasdaq Delisting, Plans to Appeal - TipRanks
Jaguar Health Received Notice of Delisting - TradingView
Jaguar Health (NASDAQ: JAGX) confronts Nasdaq delisting risk after bid-price breach - Stock Titan
JAGX Should I Buy - Intellectia AI
Jaguar Health receives $3M from Future Pak licensing deal By Investing.com - Investing.com India
Jaguar Health receives $3M from Future Pak licensing deal - Investing.com South Africa
Jaguar Animal Health Issues Racing Data Summary for Horses Participating in the Company’s Recently Completed Dose Determina... - mx.advfn.com
Jaguar Animal Health and Henry Schein, Inc. Sign Exclusive Distribution Agreement for Neonorm Foal - Revista ADVFN
Jaguar Health announces Series O preferred stock dividend and new certificate of designation - Investing.com Nigeria
Jaguar Health (JAGX) Secures $3M Payment From Future Pak - GuruFocus
Jaguar Animal Health Declares Special Series O Dividend - TipRanks
[8-K] Jaguar Health, Inc. Reports Material Event | JAGX SEC FilingForm 8-K - Stock Titan
Jaguar Health adds $3M as it targets crofelemer for rare intestinal failure - Stock Titan
Jaguar Health announces Series O preferred stock dividend and new certificate of designation By Investing.com - Investing.com India
JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jaguar Health, Inc.Common Stock (NQ: JAGX - The Chronicle-Journal
Jaguar Health (JAGX) Announces Record Date for Special Stock Div - GuruFocus
Reminder: Today, March 2, 2026, is the Record Date for Jaguar Health's Special One-time Stock Dividend - Lexington Herald Leader
Jaguar Health hands out one-time stock dividend as it weighs debt overhaul - Stock Titan
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - The Register-Guard
1.20%
0.06%
자본화:
|
볼륨(24시간):